233 related articles for article (PubMed ID: 27802345)
1. Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension.
Richter MJ; Tiede SL; Sommer N; Schmidt T; Seeger W; Ghofrani HA; Schermuly R; Gall H
PLoS One; 2016; 11(11):e0165982. PubMed ID: 27802345
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
Khirfan G; Tejwani V; Wang X; Li M; DiDonato J; Dweik RA; Smedira N; Heresi GA
PLoS One; 2018; 13(5):e0197700. PubMed ID: 29813091
[TBL] [Abstract][Full Text] [Related]
3. The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups.
Gall H; Felix JF; Schneck FK; Milger K; Sommer N; Voswinckel R; Franco OH; Hofman A; Schermuly RT; Weissmann N; Grimminger F; Seeger W; Ghofrani HA
J Heart Lung Transplant; 2017 Sep; 36(9):957-967. PubMed ID: 28302503
[TBL] [Abstract][Full Text] [Related]
4. Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.
Damico R; Kolb TM; Valera L; Wang L; Housten T; Tedford RJ; Kass DA; Rafaels N; Gao L; Barnes KC; Benza RL; Rand JL; Hamid R; Loyd JE; Robbins IM; Hemnes AR; Chung WK; Austin ED; Drummond MB; Mathai SC; Hassoun PM
Am J Respir Crit Care Med; 2015 Jan; 191(2):208-18. PubMed ID: 25489667
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension.
Säleby J; Bouzina H; Lundgren J; Rådegran G
Scand Cardiovasc J; 2017 Oct; 51(5):261-270. PubMed ID: 28776404
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension.
Enomoto N; Suzuki S; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Fujisawa T; Nakamura Y; Odagiri K; Ishikawa T; Kataoka K; Kondoh Y; Maekawa M; Inui N; Watanabe H; Suda T
Sci Rep; 2021 Jul; 11(1):15502. PubMed ID: 34326408
[TBL] [Abstract][Full Text] [Related]
9. Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism.
Naito A; Tanabe N; Jujo T; Shigeta A; Sugiura T; Sakao S; Ishida K; Tatsumi K
PLoS One; 2014; 9(11):e113086. PubMed ID: 25412085
[TBL] [Abstract][Full Text] [Related]
10. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
[TBL] [Abstract][Full Text] [Related]
11. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T
Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
Patel JV; Lim HS; Varughese GI; Hughes EA; Lip GY
Ann Med; 2008; 40(3):215-22. PubMed ID: 18382887
[TBL] [Abstract][Full Text] [Related]
13. Red Blood Cells Distribution Width as a Potential Prognostic Biomarker in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
Smukowska-Gorynia A; Tomaszewska I; Malaczynska-Rajpold K; Marcinkowska J; Komosa A; Janus M; Olasinska-Wisniewska A; Slawek S; Araszkiewicz A; Jankiewicz S; Mularek-Kubzdela T
Heart Lung Circ; 2018 Jul; 27(7):842-848. PubMed ID: 29107511
[TBL] [Abstract][Full Text] [Related]
14. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension.
Tiede SL; Wassenberg M; Christ K; Schermuly RT; Seeger W; Grimminger F; Ghofrani HA; Gall H
Int J Cardiol; 2016 Nov; 223():821-826. PubMed ID: 27575785
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of thyroid function in pulmonary hypertension.
Richter MJ; Sommer N; Schermuly R; Grimminger B; Seeger W; Tello K; Ghofrani HA; Gall H
J Heart Lung Transplant; 2016 Dec; 35(12):1427-1434. PubMed ID: 27373820
[TBL] [Abstract][Full Text] [Related]
17. ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.
Hurdman J; Condliffe R; Elliot CA; Davies C; Hill C; Wild JM; Capener D; Sephton P; Hamilton N; Armstrong IJ; Billings C; Lawrie A; Sabroe I; Akil M; O'Toole L; Kiely DG
Eur Respir J; 2012 Apr; 39(4):945-55. PubMed ID: 21885399
[TBL] [Abstract][Full Text] [Related]
18. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
[TBL] [Abstract][Full Text] [Related]
19. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
